57 episodes

Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more.

The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.

Editors in Conversation American Society for Microbiology

    • Science
    • 4.5 • 22 Ratings

Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more.

The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.

    How Can Clinical Microbiology Labs Contribute to Antimicrobial Stewardship? (JCM ed.)

    How Can Clinical Microbiology Labs Contribute to Antimicrobial Stewardship? (JCM ed.)

    Deciding how extensively to work up and report respiratory cultures is the worst. There are useful guidelines on how to approach this. But, in my experience, very few laboratories strictly follow these guidelines. That can be because of concerns about under-reporting pathogens or about over-reporting microbiota, or it can be the result of pressure from clinical staff to report more organisms than the guidelines suggest. Today, we’ll be talking with two guests about their study on how over-reporting of organisms from respiratory tract cultures can lead to over treatment with antimicrobials.
    Guests: Dr. Sarah Parker, pediatric infectious disease specialist at Children’s Hospital Colorado and the Medical Director of the Antimicrobial Stewardship Program. Dr. Andrea Prinzi, infectious disease medical science liason with bioMerieux. This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro.

    • 42 min
    Research Careers in Antimicrobial Resistance (AAC ed.)

    Research Careers in Antimicrobial Resistance (AAC ed.)

    Antimicrobial resistance is the ‘silent pandemic’ and to tackle this challenging public health problem we need to attract the best and brightest. Today we will discuss pathways to work on this field with trainees who will be the next generation of outstanding researchers in the field, currently as part of different T32 training programs in the United States. Welcome to Editors in Conversation
    Topics discussed: Different pathways to follow careers in antimicrobial research The challenges to follow an academic and research pathways Future perspectives and guidance for early stage investigators who want to pursue research on antimicrobial resistance. Guests: Cheyenne Lee.  4th Year Ph.D. Candidate | McBride Lab, Microbiology and Molecular Genetics (MMG) Program Initiative for Maximizing Student Development (IMSD) Graduate Student Representative, Emory University, Atlanta, GA. T32 predoctoral fellow Edwin Chen, MD, PhD. Infectious Diseases Fellow, Postdoctoral T32 Fellow, University of Pittsburgh. Pittsburgh, PA. Kara Hood, PhD. Pos-doctoral T32 Fellow, Texas Medical Center Program in Antimicrobial Resistance, Houston Methodist Research Institute, Houston, TX. This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up.
    Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.

    • 42 min
    Machine Learning and Artificial Intelligence in the Clinical Microbiology Laboratory (JCM ed.)

    Machine Learning and Artificial Intelligence in the Clinical Microbiology Laboratory (JCM ed.)

    The idea of applying machine learning and digital pathology platforms to everyday workflows in the clinical microbiology laboratory has become increasing intriguing and appealing, especially as labs continue to optimize efficiency in the midst of workforce shortages. The promise of this new digital frontier is multifold, including decreasing turnaround time and potentially cost, and freeing up technologist time to focus on higher yield activities in the lab. Many labs have now taken the initial leap into automated culture and imaging systems, but what’s next? Are the digital pathology AI algorithms ready for prime-time in clinical microbiology labs? Is the future now?
    Guests: Dr. Niaz Banaei, Medical Director of the Stanford Health Care Clinical Microbiology Laboratory and Professor of Pathology and Medicine at Stanford University Dr. Dan Rhoads, Section Head of Microbiology at Cleveland Clinic This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro.
    Links/Refences: Evaluation of MetaSystems automated fluorescent microscopy system for the machine-assisted detection of acid-fast bacilli in clinical samples. https://journals.asm.org/doi/10.1128/jcm.01131-22 Computer vision and artifical intelligence are emerging diagnostic tools for the clinical microbiologist. https://journals.asm.org/doi/10.1128/JCM.00511-20?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.
    Follow JCM on Twitter via @JClinMicro

    • 29 min
    How Proposed Change to US Regulation Could Impact Clinical Microbiology Labs

    How Proposed Change to US Regulation Could Impact Clinical Microbiology Labs

    There are a number of regulatory proposals under consideration which could have important effects on clinical microbiology labs, and clinical labs more generally. First, the VALID act would change how clinical tests are regulated with particularly important implications for laboratory-developed tests. Second, the Centers for Medicare and Medicaid Services has proposed changes to the educational requirements for lab directors under CLIA and additional changes that would increase the fees that clinical labs pay to CMS. If you have been waiting for someone to explain these changes and how they could affect your lab, you’ve come to the right podcast.
    Guests: Dr. Melissa Miller, Director of the Clinical Microbiology Laboratory and a Professor at the University Of North Carolina School Of Medicine Mary Lee Watts, Director of Federal Affairs at ASM This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro.
    Links: ASM Submits Concerns On VALID Act. https://asm.org/Articles/Policy/2022/May-2022/VALID-Act ASM Submits Comments to CMS on Proposed Rule for CLIA-Labs. https://asm.org/Articles/Policy/2022/Aug2022/ASM-Comments-on-CMS-Proposed-Rules-for-CLIA-Certif Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.
    Follow JCM on Twitter via @JClinMicro

    • 51 min
    Management of Mycobacterium Abscessus Infcetions: The Rise of a Superbug

    Management of Mycobacterium Abscessus Infcetions: The Rise of a Superbug

    Infections caused by Mycobacterium abscessus appear to be increasing in frequency among the immunocompromised population and are challenging to treat. Antibiotic options in these cases are scarce, prolonged therapy is required and new options are needed. We will discuss this important topic with experts in the field.
    Topics discussed: Define M. abscessus as an opportunistic pathoge The intrinsic phenotypic characteristics of M. abscessus, including resistance to common antimicrobials Treatment approaches and rationale for these strategies Guests: Kelly Dooley, MD. PhD, MPH.  Professor of Medicine, Johns Hopkins University and Editor of AAC Charles L. Daley, MD, Professor and Chief of the Division of Mycobacterial and Respiratory Infections. National Jewish Health Thomas Dick, PhD. Professor, Center for Discovery and Innovation, Hackensack Meridian Health This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up
    Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.

    • 42 min
    The Inoculum Effect of Antibiotic Susceptibility Testing

    The Inoculum Effect of Antibiotic Susceptibility Testing

    The inoculum effect of antibiotic susceptibility testing is often discussed at playgrounds and infectious diseases conferences, but many of us don’t really have a clear definition of what it is or a good understanding of its importance.
    We’ll be talking about the inoculum effect and susceptibility testing of Staphylococcus aureus with cefazolin.
    Some of the questions we’ll discuss are:
    • What exactly is the inoculum effect and how is it measured?
    • Does the inoculum effect have clinical significance?
    • How common is the inoculum effect with Staph aureus and cefazolin?

    • 25 min

Customer Reviews

4.5 out of 5
22 Ratings

22 Ratings

D20chick ,

Quality

Excellent podcast. Make more!

Top Podcasts In Science

Hidden Brain
Alie Ward
Sam Harris
Neil deGrasse Tyson
Freakonomics Radio + Stitcher
Mike Carruthers / OmniCast Media / Cumulus Podcast Network

You Might Also Like

Vincent Racaniello
Sara Dong
Vincent Racaniello
IDSA
Vincent Racaniello
Vincent Racaniello

More by American Society for Microbiology

Vincent Racaniello
Vincent Racaniello
Vincent Racaniello
Jesse Noar
Ashley Hagen, M.S.
American Society for Microbiology